Katalog der Deutschen Nationalbibliothek

Neuigkeiten Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00
 
Neuigkeiten Wegen Wartungsarbeiten ist vom 12. bis 14. Januar 2026 der Museumslesesaal, sowie vom 14. bis 16. Januar 2026 der Musiklesesaal geschlossen. // Due to maintenance work the museum reading room will be closed from 12 to 14 January 2026 and the music reading room from 14 to 16 January 2026.
 
 
 


Ergebnis der Suche nach: "106968971"
im Bestand: Gesamter Bestand

1 - 8 von 8
<< < > >>


Online Ressourcen 1 Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study
Alten, Rieke. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2016
Online Ressource
Online Ressourcen 2 Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study
Nüßlein, Hubert G.. - London : BioMed Central, 2016
Online Ressource
Online Ressourcen 3 Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study
Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2015
Online Ressource
Online Ressourcen 4 High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation
Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2014
Online Ressource
Online Ressourcen 5 Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2014
Online Ressource
Artikel 6 Obesity and risk of respiratory tract infections: results of an infection-diary based cohort study
Enthalten in BMC public health Bd. 18, 20.2.2018, Nr. 1, date:12.2018: 1-13
Online Ressource
Artikel 7 Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study
Enthalten in BMC musculoskeletal disorders Bd. 16, 30.7.2015, Nr. 1, date:12.2015: 1-11
Online Ressource
Artikel 8 Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
Enthalten in BMC musculoskeletal disorders Bd. 15, 11.1.2014, Nr. 1, date:12.2014: 1-13
Online Ressource


1 - 8 von 8
<< < > >>


E-Mail-IconAdministration